Answers are grounded in this paper and cite their sources.
This commentary discusses the mechanism of action of dimethyl sulfoxide (DMSO) in brain injuries and its potential clinical implications.
In an article published in Stroke, Pitts et al' present their experimental and clinical results with the use of dimethyl sulfoxide (DMSO) in brain injuries.Although their results were not unexpected, we found them extremely interesting, especially their well-conducted in vivo studies.We would like to comment on their statement "that the mechanism of action of DMSO is unknown" and to make some suggestions that may prove beneficial in clinical practice.Central nervous system (CNS) injury is believed to result from alteration in cellular and blood vessel function.Two of the main functional alterations have been shown to be increased cellular permeability to Na + andK + and marked diminution in the caliber of arteries, capillaries, and venules, which lead to edema and impaired circulation. 2However, theoretical and experimental evidence exists which shows that the above effects have a common cause and are due to oxidation. 3-4 Based on the above redox theory, we have conducted a number of in vitro experiments using rat aortas and dog basilar arteries and have shown that 1) simple oxidizing agents (peroxide, silver nitrate, potassium permanganate, sodium nitrate) produce vasoconstnction, 2) the concentration of agents required depends on their oxidizing potential, and 3) the vasoconstnction induced by the above agents can be inhibited and reversed by reducing agents. 5e used a number of simple chemical compounds whose sole common property is their capacity to donate electrons as reducing agents: citric acid, succinic acid, and glutathione.We also used DMSO because it too is a reducing agent and because it is a cheap, easily available compound empirically used in the treatment of a number of diseases.DMSO in all our experiments had the same effects as all the other reducing agents.However, its efficiency in inhibiting and reversing the vasoconstriction was consistently lower than that of the other reducing agents even though higher concentrations were used.It is therefore likely that DMSO produces its beneficial effects in brain injury by acting as an antioxidant.This is supported by the facts that 1) in all the major CNS disorders, there is an increase in free radical concentration and a decrease in tissue antioxidant concentration, 4 and 2) apart from DMSO, a number of other antioxidants have been found beneficial in CNS disorders. 6 Our experiments suggest that a number of other reducing agents, such as succinic acid, citric acid, and reduced glutathione, may be more effective than DMSO and at lower concentrations.
No takes yet. Share an insight, caveat, or question.
Kubota et al. (1987) conducted a letter in Central nervous system injury. Dimethyl sulfoxide (DMSO) vs. Reducing agents (citric acid, succinic acid, and glutathione) was evaluated on Inhibition and reversal of vasoconstriction induced by oxidizing agents.
Synapse has enriched 10 related papers. Consider them for comparative context: